CenterBook Partners’s Legend Biotech LEGN Stock Holding History

CenterBook Partners’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.86M	Sell	344,879 -108,028	-24%	-$2.3M	0.31%	80
2026 Q2	$13.1M	Buy	452,907 +248,304	+121%	+$6.7M	0.64%	27
2026 Q1	$3.7M	Sell	204,603 -8,421	-4%	-$161K	0.2%	133
2025 Q4	$4.63M	Buy	213,024 +67,493	+46%	+$1.93M	0.23%	117
2025 Q3	$4.75M	Buy	145,531 +39,863	+38%	+$1.47M	0.23%	116
2025 Q2	$3.75M	Buy	105,668 +30,789	+41%	+$998K	0.21%	131
2025 Q1	$2.54M	Sell	74,879 -48,912	-40%	-$1.75M	0.16%	163
2024 Q4	$4.03M	Buy	123,791 +48,126	+64%	+$1.99M	0.24%	123
2024 Q3	$3.69M	Sell	75,665 -78,409	-51%	-$4.18M	0.23%	122
2024 Q2	$6.82M	Buy	+154,074	New	+$7.11M	0.42%	67

Other funds holding LEGN

Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

iA Global Asset Management Quebec, Quebec, Canada $8.54B AUM 39.73% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

CenterBook Partners's LEGN Position: Q3 2026 in Review

CenterBook Partners reduced its Legend Biotech (LEGN) stake by 24% in Q3 2026, selling an estimated $2.3M and leaving 344,879 shares worth $6.86M. The position accounts for 0.31% of the portfolio, ranked #80.

CenterBook Partners first reported a position in LEGN in Q2 2024 and has held it in 10 quarters since. The position peaked at $13.1M in Q2 2026. 51 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

CenterBook Partners held 344,879 shares of Legend Biotech worth $6.86M as of Q3 2026.
CenterBook Partners sold 108,028 Legend Biotech shares in Q3 2026, an estimated $2.3M.
Legend Biotech made up 0.31% of CenterBook Partners's portfolio in Q3 2026, its #80 holding.
CenterBook Partners first reported a position in Legend Biotech in Q2 2024 and has held it in 10 quarters since.
CenterBook Partners's Legend Biotech position peaked at $13.1M in Q2 2026.
51 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.